Brief: RxSight Receives FDA Notification That Additional Information Will Be Required For Approval Of Light Delivery Device

RxSight

11/07/2022 22:21

July 11 (Reuters) - Rxsight Inc  RXST.O :
    * RXSIGHT- ON JUNE 30 RECEIVED NOTIFICATION FROM FDA THAT
ADDITIONAL INFORMATION WILL BE REQUIRED FOR APPROVAL OF
LOWER-COST-TO-MANUFACTURE LIGHT DELIVERY DEVICE
    * RXSIGHT- BELIEVES IT CAN PROVIDE  REQUESTED INFORMATION TO
FDA
AND OBTAIN FDA APPROVAL WITHOUT IMPACTING ITS COMMERCIAL
INTRODUCTION TIMELINE

Source text: (https://bit.ly/3uHKxdg)
Further company coverage:  RXST.O 

 ((Reuters.Briefs@thomsonreuters.com;))